Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.
This report contains market size and forecasts of Hyaluronidase in global, including the following market information:
Global Hyaluronidase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hyaluronidase Market Sales, 2017-2022, 2023-2028, (L)
Global top five Hyaluronidase companies in 2021 (%)
The global Hyaluronidase market was valued at 823.8 million in 2021 and is projected to reach US$ 1248.1 million by 2028, at a CAGR of 6.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Animal-derived Hyaluronidase Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hyaluronidase include PrimaPharm, Bausch Health, Amphastar Pharmaceuticals, Halozyme Therapeutics, CooperSurgical Fertility, Shreya Life Sciences, Sun Pharmaceutical Industries, CBC Pharma and STEMCELL Technologies. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hyaluronidase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyaluronidase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Hyaluronidase Market Segment Percentages, by Type, 2021 (%)
Animal-derived Hyaluronidase
Synthetic Hyaluronidase
Global Hyaluronidase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Hyaluronidase Market Segment Percentages, by Application, 2021 (%)
Dermatology
Plastic Surgery
Global Hyaluronidase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Hyaluronidase Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyaluronidase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hyaluronidase revenues share in global market, 2021 (%)
Key companies Hyaluronidase sales in global market, 2017-2022 (Estimated), (L)
Key companies Hyaluronidase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
PrimaPharm
Bausch Health
Amphastar Pharmaceuticals
Halozyme Therapeutics
CooperSurgical Fertility
Shreya Life Sciences
Sun Pharmaceutical Industries
CBC Pharma
STEMCELL Technologies